Ophthalmologic findings in patients using levodopa.
D000328:Adult; D000368:Aged; D000867:Anterior Chamber / Q000187:drug effects; D002924:Ciliary Body / Q000187:drug effects; D003315:Cornea / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005123:Eye / Q000187:drug effects*; D005260:Female; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006068:Gonioscopy; D006801:Humans; D007498:Iris / Q000187:drug effects; D007908:Lens, Crystalline / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010858:Pigmentation / Q000187:drug effects; D011680:Pupil / Q000187:drug effects; D012590:Sclera / Q000187:drug effects; D013997:Time Factors; D014785:Vision, Ocular / Q000187:drug effects*; D014792:Visual Acuity / Q000187:drug effects; D014794:Visual Fields / Q000187:drug effects
D004295:Dihydroxyphenylalanine